On this page
- Why this question is asked so often
- How cell therapies get classified
- What to check rather than take on trust
- Facility and practitioner licensing
- The trial exemption, and how it gets misused
- What a lawful treatment still does not tell you
- How this compares internationally
- Practical position
- Frequently asked questions
- Requesting a medical evaluation
Availability is not approval, and the gap between those two words explains most of the medical travel in this field. Stem cell regulation in Thailand is neither absent nor identical to Europe or the United States, and understanding roughly where it sits is more useful than either the “anything goes” caricature or the reassurance offered by clinics selling the treatment.
Why this question is asked so often
People arrive at it from the wrong direction. Having discovered a treatment is unavailable at home but purchasable in Bangkok, the natural inference is that Thailand permits what others forbid.
That inference is half right and misleading in the half that matters. Regulatory systems differ in what they classify as a drug, what they classify as a medical procedure, and how vigorously either is enforced.
None of those differences tell you anything about whether a treatment works, and treating legality as a proxy for evidence is the single most common error made in this decision.
The reverse error is just as common in the other direction — assuming that because something is sold abroad it must be dubious. Plenty of legitimate medicine is available in one country before another, for reasons that have nothing to do with quality.
How cell therapies get classified
Broadly, regulators everywhere draw a line between tissue that is minimally manipulated and returned to the same person, and cells that have been substantially processed — expanded in culture, combined with other substances, or used for a function they do not ordinarily perform.
The first category is often treated as a medical procedure. The second is generally treated as a manufactured biological product requiring approval supported by trial evidence.
Almost everything discussed on this site falls into the second category, because culture expansion is what makes a therapeutic dose possible — see MSC therapy.
Donor-derived products sit further into that category again, since they are unambiguously manufactured rather than returned — see cord-derived therapy.
What to check rather than take on trust
Regulation changes, and a page written today is a poor substitute for a current official source. These are the places to look rather than asking a clinic.
- Thailand’s Food and Drug Administration, for how the product itself is classified
- The Ministry of Public Health, for the licensing of the facility
- The Medical Council of Thailand, for the registration of the doctor treating you
- Clinical trial registries, if you are told something is part of a study
Each of those is verifiable independently, which is the point. A clinic’s own description of its regulatory status is the least useful evidence available.
Facility and practitioner licensing
Two separate questions that are easily conflated. Whether the clinic is licensed to operate is not the same as whether the specific treatment is approved, and neither is the same as whether the doctor is registered to give it.
A licensed facility can lawfully offer procedures that no regulator has approved as products, in the same way a licensed restaurant can serve a bad meal.
Ask for all three separately: facility licence, practitioner registration, and the regulatory status of the specific preparation. A clinic that conflates them when answering is either unclear about its own position or hoping you will be.
The trial exemption, and how it gets misused
Most jurisdictions allow unapproved treatments within properly constituted clinical trials — with ethics approval, a registered protocol, informed consent and reporting of results.
That is a genuine and important route. It is also occasionally invoked loosely by clinics charging commercial prices for treatment described as research.
A real trial has a registry entry you can find, does not usually charge full commercial rates, and reports its results whether they are favourable or not. If you are told your treatment is part of a study, ask for the registration number and look it up.
The same applies to consent paperwork. A trial consent form names the protocol, the sponsor and the ethics committee that approved it, and describes what happens to your data. A commercial consent form mostly describes what happens if you are dissatisfied.
What a lawful treatment still does not tell you
That it works. Legality and efficacy are decided by different bodies against different standards.
That the dose is sensible, or that the cells were prepared to any particular standard — those depend on the facility, not the law.
That your own insurer will pay, or that a complication will be covered — see the cost page.
And that it suits your condition, which is a clinical question that no regulatory framework answers — see what the evidence levels mean.
How this compares internationally
The United States regulates most expanded cell preparations as drugs requiring approval, which is why availability differs so sharply — see the US comparison.
Mexico and Turkey are the other destinations patients commonly weigh, each with its own framework and its own enforcement pattern — see Mexico and Turkey.
Comparing them on permissiveness alone misses the more useful comparison, which is what documentation you can actually obtain and verify in each.
Practical position
Treat regulatory status as one input among several, and a weak one. It tells you what may lawfully be sold, not what is worth buying.
Verify the facility licence, the doctor’s registration and the product’s classification separately, from official sources rather than from marketing.
Then set all of that aside and ask the evidence question independently — see the research library. A treatment can be entirely lawful and still be a poor use of your money, and no licence anywhere resolves that.
Frequently asked questions
Is stem cell therapy legal in Thailand?
Thailand regulates cell therapy, and the answer depends on how the specific preparation is classified. Check the Thai FDA and Ministry of Public Health rather than a clinic’s own description.
Does legal mean approved?
No. A licensed facility can lawfully offer procedures no regulator has approved as products. Those are separate questions.
Why is it available here and not at home?
Different classification and different enforcement, not different evidence. The underlying research is identical in both countries.
What should I verify myself?
Facility licence, the doctor’s registration with the Medical Council, and the regulatory status of the specific preparation. All three are checkable independently.
I was told my treatment is part of a trial.
Ask for the registry number and look it up. A real trial is registered, reports results, and does not usually charge full commercial rates.
Does lawful mean safe?
No. Dose, preparation standards and testing depend on the facility rather than on the law, and those are where documented harms cluster.
Requesting a medical evaluation
Nothing on this page establishes whether any treatment is appropriate for you. That needs your history, your imaging and your current medications read by a clinician. If you would like that review, send your records and we will tell you honestly whether there is anything worth discussing — including when the answer is no.
This page is general information, not medical advice, and does not create a doctor–patient relationship. Regenerative treatments discussed here are in most cases investigational. Discuss any treatment with a clinician who knows your history.